Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis
Author:
Affiliation:
1. Sunovion Pharmaceuticals Inc, Marlborough, MA, USA
2. IQVIA, Falls Church, VA, USA
Funder
Sunovion
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1845185
Reference46 articles.
1. American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. 2013 [cited 2020 Jun 23]. Available from: https://www.lung.org/getmedia/4f74781e-481f-4f10-9255-8dfc9dc56974/copd-trend-report.pdf.pdf
2. Centers for Disease Control and Prevention. Leading causes of death. 2017 [cited 2020 Jun 26]. Available from: https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm
3. Hospital Discharges, Readmissions, and ED Visits for COPD or Bronchiectasis Among US Adults
4. Characteristics of COPD Patients Using United States Emergency Care or Hospitalization
5. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS)
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tactical Considerations for Designing Real-World Studies: Fit-for-Purpose Designs That Bridge Research and Practice;Pragmatic and Observational Research;2023-09
2. Internet-of-Things-Based Sensor Module for Respiratory Tracking System;IEEE Sensors Journal;2023-08-15
3. People with Diabetics React Less to COVID-19 Vaccinations Without Increased Risk of Break-through Infections: An Observational Study from Community Reporters (Preprint);JMIR Diabetes;2023-01-05
4. Diabetics React Less to COVID-19 Vaccinations Without Increased Risk of Break-through Infections: An Observational Study from Community Reporters (Preprint);2023-01-05
5. Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD;npj Primary Care Respiratory Medicine;2021-10-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3